Accordingly, the progression of many autoimmune disorders, including experimental autoimmune encephalomyelitis (EAE) (75), diabetes, and colitis, was promoted when the interaction between PD-1 and B7-H1 was inhibited (76, 77). Here, PDCD1 is linked to colitis.